OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
AMBS
Amarantus Bioscience Holdings, Inc.
On October 24, 2018, Amarantus Biocience Holdings, Inc. (OTCPK: AMBS, AMBS, or the Company) withdrew a binding offer for a joint venture (the JV) between MER Telemanagement Solutions Ltd. (NASDAQ:MTSL, MTSL) that was initially proposed by the Company on October 18, 2018. The Company will continue to pursue strategic opportunities for its subsidiaries.
